Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Unyvero ITI® system for the clinical resolution of discrepancies in periprosthetic joint infection diagnosis.

Zannoli S, Sambri A, Morotti M, Tassinari M, Torri A, Bianchi G, De Paolis M, Donati DM, Sambri V.

Musculoskelet Surg. 2019 Oct 8. doi: 10.1007/s12306-019-00626-x. [Epub ahead of print]

PMID:
31595427
2.

Diagnostic flow-chart to identify bowel involvement in patients with stage IIIC-IV ovarian cancer: Can laparoscopy improve the accuracy of CT scan?

Tozzi R, Traill Z, Campanile RG, Kilic Y, Baysal A, Giannice R, Morotti M, Soleymani Majd H, Valenti G.

Gynecol Oncol. 2019 Aug 31. pii: S0090-8258(19)31477-5. doi: 10.1016/j.ygyno.2019.08.025. [Epub ahead of print]

PMID:
31481247
3.

Surgical treatment of large adnexal masses: a retrospective analysis of 330 consecutive cases.

Casarin J, Laganà AS, Uccella S, Cromi A, Pinelli C, Gisone B, Borghi C, Cominotti S, Garzon S, Morotti M, Tozzi R, Ghezzi F.

Minim Invasive Ther Allied Technol. 2019 Aug 2:1-9. doi: 10.1080/13645706.2019.1649700. [Epub ahead of print]

PMID:
31375049
4.

Morbidity of multiple bowel resection compared to single bowel resection after debulking surgery for ovarian cancer.

Tozzi R, Casarin J, Baysal A, Pinelli C, Matak L, Ghanbarzadeh N, Alazzam M, Garruto-Campanile R, Majd HS, Kilic Y, Morotti M.

Eur J Obstet Gynecol Reprod Biol. 2019 Sep;240:215-219. doi: 10.1016/j.ejogrb.2019.07.011. Epub 2019 Jul 13.

PMID:
31326636
5.

Erratum: Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC-IV ovarian cancer.

Tozzi R, Casarin J, Baysal A, Valenti G, Kilic Y, Majd HS, Morotti M.

J Gynecol Oncol. 2019 Sep;30(5):e101. doi: 10.3802/jgo.2019.30.e101. Epub 2019 Jun 3.

6.

Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer.

Morotti M, Bridges E, Valli A, Choudhry H, Sheldon H, Wigfield S, Gray N, Zois CE, Grimm F, Jones D, Teoh EJ, Cheng WC, Lord S, Anastasiou D, Haider S, McIntyre A, Goberdhan DCI, Buffa F, Harris AL.

Proc Natl Acad Sci U S A. 2019 Jun 18;116(25):12452-12461. doi: 10.1073/pnas.1818521116. Epub 2019 May 31.

7.

Comparison of the Novel Immunocatch Legionella Test with Sofia Legionella FIA Assay and with BinaxNOW Legionella Card Assay for Detection of Legionella pneumophila (Serogroup 1) Antigen in Urine Samples.

Congestrì F, Morotti M, Vicari R, Pedna MF, Sparacino M, Torri A, Bertini S, Sambri V.

J Clin Microbiol. 2019 Jul 26;57(8). pii: e00305-19. doi: 10.1128/JCM.00305-19. Print 2019 Aug.

PMID:
31092595
8.

Adaptation to HIF1α Deletion in Hypoxic Cancer Cells by Upregulation of GLUT14 and Creatine Metabolism.

Valli A, Morotti M, Zois CE, Albers PK, Soga T, Feldinger K, Fischer R, Frejno M, McIntyre A, Bridges E, Haider S, Buffa FM, Baban D, Rodriguez M, Yanes O, Whittington HJ, Lake HA, Zervou S, Lygate CA, Kessler BM, Harris AL.

Mol Cancer Res. 2019 Jul;17(7):1531-1544. doi: 10.1158/1541-7786.MCR-18-0315. Epub 2019 Mar 18.

PMID:
30885992
9.

Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC-IV ovarian cancer.

Tozzi R, Casarin J, Baysal A, Valenti G, Kilic Y, Majd HS, Morotti M.

J Gynecol Oncol. 2019 Mar;30(2):e25. doi: 10.3802/jgo.2019.30.e25. Epub 2018 Nov 30. Erratum in: J Gynecol Oncol. 2019 Sep;30(5):e101.

10.

An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment.

Motohara T, Masuda K, Morotti M, Zheng Y, El-Sahhar S, Chong KY, Wietek N, Alsaadi A, Karaminejadranjbar M, Hu Z, Artibani M, Gonzalez LS, Katabuchi H, Saya H, Ahmed AA.

Oncogene. 2019 Apr;38(16):2885-2898. doi: 10.1038/s41388-018-0637-x. Epub 2018 Dec 19. Review.

11.

Multicenter performance evaluation of the Unyvero IAI cartridge for detection of intra-abdominal infections.

Ciesielczuk H, Wilks M, Castelain S, Choquet M, Morotti M, Pluquet E, Sambri V, Tassinari M, Zannoli S, Cavalié L, Dupont H, Guet-Revillet H.

Eur J Clin Microbiol Infect Dis. 2018 Nov;37(11):2107-2115. doi: 10.1007/s10096-018-3345-0. Epub 2018 Aug 10.

PMID:
30094522
12.

Concomitant Laparoscopic and Thoracoscopic Resection of Recurrent High-Grade Ovarian Cancer.

Tozzi R, Casarin J, Belcher E, Garruto Campanile R, Ismail L, Soleymani Majd H, Morotti M, Desgro M.

J Minim Invasive Gynecol. 2018 Nov - Dec;25(7):1148. doi: 10.1016/j.jmig.2018.02.014. Epub 2018 Mar 2.

PMID:
29501813
13.

Microbiological surveillance of plasmid mediated colistin resistance in human Enterobacteriaceae isolates in Romagna (Northern Italy): August 2016-July 2017.

Del Bianco F, Morotti M, Pedna MF, Farabegoli P, Sambri V.

Int J Infect Dis. 2018 Apr;69:96-98. doi: 10.1016/j.ijid.2018.02.006. Epub 2018 Feb 12.

14.

Morbidity and reversal rate of ileostomy after bowel resection during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer.

Tozzi R, Casarin J, Garruto-Campanile R, Majd HS, Morotti M.

Gynecol Oncol. 2018 Jan;148(1):74-78. doi: 10.1016/j.ygyno.2017.11.017. Epub 2017 Nov 20.

PMID:
29169615
15.

Pharmacodynamic and Pharmacokinetic Markers For Anti-angiogenic Cancer Therapy: Implications for Dosing and Selection of Patients.

Morotti M, Dass PH, Harris AL, Lord S.

Eur J Drug Metab Pharmacokinet. 2018 Apr;43(2):137-153. doi: 10.1007/s13318-017-0442-x. Review.

PMID:
29019020
16.

Retrospective Cohort Analysis of Liposomal Amphotericin B Nephrotoxicity in Patients with Hematological Malignancies.

Stanzani M, Vianelli N, Cavo M, Maritati A, Morotti M, Lewis RE.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e02651-16. doi: 10.1128/AAC.02651-16. Print 2017 Sep.

17.

Efficacy and acceptability of long-term norethindrone acetate for the treatment of rectovaginal endometriosis.

Morotti M, Venturini PL, Biscaldi E, Racca A, Calanni L, Vellone VG, Stabilini C, Ferrero S.

Eur J Obstet Gynecol Reprod Biol. 2017 Jun;213:4-10. doi: 10.1016/j.ejogrb.2017.03.033. Epub 2017 Mar 27.

PMID:
28384540
18.

Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older.

Conti F, Brillanti S, Buonfiglioli F, Vukotic R, Morelli MC, Lalanne C, Massari M, Foschi FG, Bernabucci V, Serio I, Prati GM, Negri E, Badia L, Caraceni P, Muratori P, Vitale G, Porro A, Morotti M, Mazzella G, Andreone P.

J Viral Hepat. 2017 Jun;24(6):454-463. doi: 10.1111/jvh.12663. Epub 2017 Feb 2.

PMID:
27976461
19.

Mechanisms of pain in endometriosis.

Morotti M, Vincent K, Becker CM.

Eur J Obstet Gynecol Reprod Biol. 2017 Feb;209:8-13. doi: 10.1016/j.ejogrb.2016.07.497. Epub 2016 Aug 3. Review.

PMID:
27522645
20.

The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer.

da Motta LL, Ledaki I, Purshouse K, Haider S, De Bastiani MA, Baban D, Morotti M, Steers G, Wigfield S, Bridges E, Li JL, Knapp S, Ebner D, Klamt F, Harris AL, McIntyre A.

Oncogene. 2017 Jan 5;36(1):122-132. doi: 10.1038/onc.2016.184. Epub 2016 Jun 13.

21.

LYMPHA Technique to Prevent Secondary Lower Limb Lymphedema.

Boccardo F, Valenzano M, Costantini S, Casabona F, Morotti M, Sala P, De Cian F, Molinari L, Spinaci S, Dessalvi S, Campisi CC, Villa G, Campisi C.

Ann Surg Oncol. 2016 Oct;23(11):3558-3563. doi: 10.1245/s10434-016-5282-4. Epub 2016 May 24.

PMID:
27221358
22.

Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival.

Choudhry H, Albukhari A, Morotti M, Haider S, Moralli D, Smythies J, Schödel J, Green CM, Camps C, Buffa F, Ratcliffe P, Ragoussis J, Harris AL, Mole DR.

Oncogene. 2015 Aug 20;34(34):4546. doi: 10.1038/onc.2014.431.

PMID:
26289678
23.

Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment.

Morotti M, Sozzi F, Remorgida V, Venturini PL, Ferrero S.

Eur J Obstet Gynecol Reprod Biol. 2014 Dec;183:188-92. doi: 10.1016/j.ejogrb.2014.10.036. Epub 2014 Oct 30.

PMID:
25461377
24.

Progestin-only contraception compared with extended combined oral contraceptive in women with migraine without aura: a retrospective pilot study.

Morotti M, Remorgida V, Venturini PL, Ferrero S.

Eur J Obstet Gynecol Reprod Biol. 2014 Dec;183:178-82. doi: 10.1016/j.ejogrb.2014.10.029. Epub 2014 Nov 10.

PMID:
25461375
25.

Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival.

Choudhry H, Albukhari A, Morotti M, Haider S, Moralli D, Smythies J, Schödel J, Green CM, Camps C, Buffa F, Ratcliffe P, Ragoussis J, Harris AL, Mole DR.

Oncogene. 2015 Aug 20;34(34):4482-90. doi: 10.1038/onc.2014.378. Epub 2014 Nov 24. Erratum in: Oncogene. 2015 Aug 20;34(34):4546.

26.

Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine without aura.

Morotti M, Remorgida V, Venturini PL, Ferrero S.

Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:63-8. doi: 10.1016/j.ejogrb.2014.05.016. Epub 2014 Jun 2.

PMID:
24965982
27.

Central changes associated with chronic pelvic pain and endometriosis.

Brawn J, Morotti M, Zondervan KT, Becker CM, Vincent K.

Hum Reprod Update. 2014 Sep-Oct;20(5):737-47. doi: 10.1093/humupd/dmu025. Epub 2014 Jun 11. Review.

28.

Intraoperative frozen section risk assessment accurately tailors the surgical staging in patients affected by early-stage endometrial cancer: the application of 2 different risk algorithms.

Sala P, Morotti M, Menada MV, Cannavino E, Maffeo I, Abete L, Fulcheri E, Menoni S, Venturini P, Papadia A.

Int J Gynecol Cancer. 2014 Jul;24(6):1021-6. doi: 10.1097/IGC.0000000000000145.

PMID:
24905611
29.

Peripheral changes in endometriosis-associated pain.

Morotti M, Vincent K, Brawn J, Zondervan KT, Becker CM.

Hum Reprod Update. 2014 Sep-Oct;20(5):717-36. doi: 10.1093/humupd/dmu021. Epub 2014 May 23. Review.

30.

Changes in sexual function after medical or surgical termination of pregnancy.

Morotti M, Calanni L, Gianola G, Anserini P, Venturini PL, Ferrero S.

J Sex Med. 2014 Jun;11(6):1495-504. doi: 10.1111/jsm.12506. Epub 2014 Mar 18.

PMID:
24636172
31.

Targeting tyrosine-kinases in ovarian cancer.

Morotti M, Becker CM, Menada MV, Ferrero S.

Expert Opin Investig Drugs. 2013 Oct;22(10):1265-79. doi: 10.1517/13543784.2013.816282. Epub 2013 Jul 2. Review.

PMID:
23815710
32.

Lymphedema microsurgical preventive healing approach for primary prevention of lower limb lymphedema after inguinofemoral lymphadenectomy for vulvar cancer.

Morotti M, Menada MV, Boccardo F, Ferrero S, Casabona F, Villa G, Campisi C, Papadia A.

Int J Gynecol Cancer. 2013 May;23(4):769-74. doi: 10.1097/IGC.0b013e318287a8e8.

PMID:
23485932
33.

Diaphragmatic surgery during cytoreduction for primary or recurrent epithelial ovarian cancer: a review of the literature.

Papadia A, Morotti M.

Arch Gynecol Obstet. 2013 Apr;287(4):733-41. doi: 10.1007/s00404-013-2715-1. Epub 2013 Jan 23. Review.

PMID:
23341061
34.

Antiangiogenic drugs in the treatment of endometriosis.

Morotti M, Ferrero S.

Reprod Sci. 2013 Mar;20(3):NP1-2. doi: 10.1177/1933719112468955. Epub 2012 Dec 28. No abstract available.

PMID:
23275467
35.

Endometriosis in menopause: a single institution experience.

Morotti M, Remorgida V, Venturini PL, Ferrero S.

Arch Gynecol Obstet. 2012 Dec;286(6):1571-5. doi: 10.1007/s00404-012-2473-5. Epub 2012 Jul 24.

PMID:
22825693
36.

Comparing treatments for endometriosis-related pain symptoms in patients with migraine without aura.

Morotti M, Remorgida V, Buccelli E, Venturini PL, Ferrero S.

J Comp Eff Res. 2012 Jul;1(4):347-57. doi: 10.2217/cer.12.38. Review.

PMID:
24237468
37.

Bevacizumab in endometrial cancer treatment.

Morotti M, Valenzano Menada M, Venturini PL, Ferrero S.

Expert Opin Biol Ther. 2012 May;12(5):649-58. doi: 10.1517/14712598.2012.672558. Epub 2012 Mar 20.

PMID:
22428875
38.

Frozen section pathology at time of hysterectomy accurately predicts endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia.

Morotti M, Menada MV, Moioli M, Sala P, Maffeo I, Abete L, Fulcheri E, Menoni S, Venturini P, Papadia A.

Gynecol Oncol. 2012 Jun;125(3):536-40. doi: 10.1016/j.ygyno.2012.02.011. Epub 2012 Feb 21.

PMID:
22361087
39.

Pemetrexed disodium in ovarian cancer treatment.

Morotti M, Valenzano Menada M, Venturini PL, Mammoliti S, Ferrero S.

Expert Opin Investig Drugs. 2012 Apr;21(4):437-49. doi: 10.1517/13543784.2012.661714. Epub 2012 Feb 13. Review.

PMID:
22324304
40.

The preoperative diagnosis of borderline ovarian tumors: a review of current literature.

Morotti M, Menada MV, Gillott DJ, Venturini PL, Ferrero S.

Arch Gynecol Obstet. 2012 Apr;285(4):1103-12. doi: 10.1007/s00404-011-2194-1. Epub 2011 Dec 31. Review.

PMID:
22210294
41.

Defective placental adhesion in voluntary termination of second-trimester pregnancy and risk of recurrence in subsequent pregnancies.

Morotti M, Podestà S, Musizzano Y, Venturini PL, Bentivoglio G, Fulcheri E, Ferrero S.

J Matern Fetal Neonatal Med. 2012 Apr;25(4):339-42. doi: 10.3109/14767058.2011.576722. Epub 2011 May 24.

PMID:
21609201
42.

Pharmacokinetic and toxicity considerations for the use of anthracyclines in ovarian cancer treatment.

Morotti M, Valenzano Menada M, Venturini PL, Ferrero S.

Expert Opin Drug Metab Toxicol. 2011 Jun;7(6):707-20. doi: 10.1517/17425255.2011.570330. Epub 2011 Mar 24. Review.

PMID:
21434836
43.

Multidetector computerized tomography enteroclysis vs. rectal water contrast transvaginal ultrasonography in determining the presence and extent of bowel endometriosis.

Ferrero S, Biscaldi E, Morotti M, Venturini PL, Remorgida V, Rollandi GA, Valenzano Menada M.

Ultrasound Obstet Gynecol. 2011 May;37(5):603-13. doi: 10.1002/uog.8971. Epub 2011 Apr 5.

44.

Transvaginal ultrasonography with water-contrast in the rectum in the diagnosis of bowel endometriosis.

Morotti M, Ferrero S, Bogliolo S, Venturini PL, Remorgida V, Valenzano Menada M.

Minerva Ginecol. 2010 Jun;62(3):179-85. Review. English, Italian.

PMID:
20595942
45.

Breast cancer with synchronous massive metastasis in the uterine cervix: a case report and review of the literature.

Bogliolo S, Morotti M, Valenzano Menada M, Fulcheri E, Musizzano Y, Casabona F.

Arch Gynecol Obstet. 2010 Apr;281(4):769-73. doi: 10.1007/s00404-009-1264-0. Epub 2009 Oct 30. Review.

PMID:
19876639
46.

Genetic safety evaluation of pesticides in different short-term tests.

Hrelia P, Vigagni F, Maffei F, Morotti M, Colacci A, Perocco P, Grilli S, Cantelli-Forti G.

Mutat Res. 1994 Jun;321(4):219-28.

PMID:
7515160
47.

The modulating activity of interferon on benzo(a)pyrene bioactivation and clastogenesis in mice.

Hrelia P, Morotti M, Vigagni F, Maffei F, Paolini M, Mesirca R, Cantelli-Forti G.

Pharmacol Toxicol. 1994 Apr-May;74(4-5):249-54.

PMID:
8090695
48.

Synthesis of a series of 5-nitro-(benzimidazoles and indoles) as novel antimycotics and evaluation as genotoxins in the Ames test.

Hrelia P, Morotti M, Vigagni F, Burnelli S, Garuti L, Sabatino P, Cantelli-Forti G.

Mutagenesis. 1993 May;8(3):183-8.

PMID:
8332079
49.

Mechanism of genotoxicity and electron density distribution by NMR of 5-nitro-3-thiophenecarboxamides, a novel group of direct-acting mutagens in Salmonella typhimurium.

Hrelia P, Vigagni F, Morotti M, Forti GC, Barbieri CL, Spinelli D, Lamartina L.

Chem Biol Interact. 1993 Mar;86(3):229-54.

PMID:
8485786
50.

Murine alpha/beta interferons inhibit benzo(a)pyrene activation and mutagenesis in mice.

Hrelia P, Morotti M, Vigagni F, Maffei F, Paolini M, Forti GC.

Basic Life Sci. 1993;61:325-34.

PMID:
8304945

Supplemental Content

Loading ...
Support Center